Industries · pharma

Secure remote access for pharmaceutical manufacturing

Pharmaceutical production environments rely on specialist systems, vendor-maintained equipment, production lines, packaging lines, facilities systems and controlled maintenance windows. Remote access must support operational work without weakening governance, evidence or control.

The access problem

The access problem in pharmaceutical manufacturing

Remote support in pharmaceutical environments often involves multiple groups: internal engineering, automation teams, system integrators, OEMs and maintenance providers. Each group may have its own access method, credentials and support workflow. That creates friction for operations and gaps for security and audit teams.

  • Vendor-maintained production systems
  • Maintenance windows tied to change processes
  • Production and facilities environments with different constraints
  • Multiple third-party access methods
  • Need for evidence after remote interventions
  • Pressure to support issues quickly without losing control
Common scenarios

Where controlled remote access matters.

Support for production and packaging lines

Vendor access to specialist equipment

Remote diagnostics during approved maintenance windows

Access to facilities and utility systems

Engineering support for automation environments

Evidence collection after remote work

The control model

How Otector controls access

Otector gives pharmaceutical manufacturers a client-controlled access layer for remote work. Access can be approved per asset, user, provider, reason and time window. Sessions can be monitored and recorded, and activity can be retained as evidence for review, investigation and security programs.

  • Time-windowed access
  • Approval workflows
  • Service-provider access
  • Browser-based sessions
  • Controlled native-tool access where approved
  • Session recordings
  • Audit trail
  • File movement controls
Service-provider and vendor access

Give specialists access without giving up control.

OEMs, integrators and specialist maintenance providers can request a defined path to the equipment they support. The manufacturer keeps authority over access scope, timing, credentials and evidence across production, packaging and facilities environments.

Explore service-provider access
Monitoring, recording and audit evidence

Keep a reviewable record of remote work.

Otector helps create a structured record of remote access activity: who connected, what they accessed, when they connected, why access was approved and what happened during the session.

Explore audit evidence
Security architecture

Designed around OT network boundaries.

Otector separates the user experience from site connectivity. The Site Agent initiates its connection outward and brokers only the approved profile, supporting controlled access without a broad inbound path.

View security architecture
Related use cases

Explore the access challenge.

FAQ

Questions about remote access in this environment.

Can Otector help with access evidence in pharmaceutical environments?

Otector helps retain remote access evidence such as approvals, users, assets, timestamps, recordings, alerts and audit logs. It does not by itself certify or validate a regulated process.

Can vendor access be approved per maintenance window?

Yes. Access can be requested and approved for defined time windows and purposes.

Does Otector control file movement?

Otector includes file transfer controls that can help govern uploads, downloads and release decisions depending on configuration.

Can native engineering tools be used?

Where approved, Otector Tunnels can provide scoped native-tool access without creating a general VPN route.

Who controls credentials and policy?

The client remains authoritative for credentials, access scope, policies and audit data.

See Otector in context

Bring control to remote access in your environment.

Walk through your current access paths with our team and see how approvals, session controls and evidence fit together.